Please assess the completion status of the following clinical trial:

Trial Title: Bupropion Treatment for Youth Smoking Cessation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* 14 to 17 years of age~* Smoked at least 6 cigarettes per day~* Exhaled CO greater than or equal to 10 ppm~* Made at least two previous quit attempts~* Weighed at least 90 pounds~* Able to read English at least the 6th grade level~* Motivated to quit smoking as evidenced by willingness to commit to study protocol requirements for the duration of the study~* provided active parental consent and youth assent~Exclusion Criteria:~* Current use of tobacco products other than cigarettes, unless willing to abstain from these products for the study duration~* Current use of other treatments for smoking cessation~* History or current diagnosis of panic disorder, psychosis, bipolar disorder, or eating disorder~* History of abuse or dependence on alcohol or other recreational or prescription drugs in the three months preceding the study~* Current evidence of clinical depression or Attention Deficit/Hyperactivity Disorder~* Use of any psychoactive drug and/or any type of antidepressant with in four weeks of the treatment phase of the study~* Predisposition to seizure or tic disorders or a personal history of a seizure disorder, family history of seizure disorders, or treatment with medication or therapies that increase the risk of seizures~* Significant history of or current clinical evidence of cardiovascular disease~* (Females)Pregnancy (urine pregnancy test), lactation or, if sexually active, unwillingness to use a medically acceptable form of contraception for the duration of the study~* Only one member of a household was allowed to participate in the study concurrently.

- Gender: ALL
- Minimum Age: 14 Years
- Maximum Age: 17 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).